RxDoctor Payments Data

Eugene Galperin, MD

Nephrology · San Luis Obispo, CANPI 1548318330

Payments from drug & device makers

$65,203in general payments, 2019–2025

Across 34 payments — averaging $1917.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$58K
  • AstraZeneca$7K
  • Baxter Healthcare$862
  • Vifor Pharma, Inc.$200

What the payments were for

  • Consulting fees$86281%
  • Speaking & faculty fees$20019%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK31$57,547
AstraZeneca1$6,594
Baxter Healthcare1$862
Vifor Pharma, Inc.1$200

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,203 in reported general payments places this provider in the 85th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California

Medicare billing

Part B allowed, 2024
$3,029
Medicare patients
24
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in San Luis Obispo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →